Abstract

Clopidogrel 5-mg/mL Oral Suspension

Author(s): Allen Loyd V Jr

Issue: Mar/Apr 2011 - Volume 15, Number 2

Page(s): 158

Download in electronic PDF format for $75
  • Clopidogrel 5-mg/mL Oral Suspension Page 1

Abstract

A formulation for preparing Clopidogrel 5-mg/mL Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulations
  • clopidogrel
  • antiplatelet agent
  • thromboembolism
  • blood clots
  • clotting disorders
  • prevention

Related Categories

  • FORMULATIONS
  • CARDIOLOGY
  • HEMOSTASIS, BLEEDING, ANTICOAGULATION

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2011
Pg. 158
Clopidogrel 5-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2011
Pg. 435-437
Stability of Clopidogrel in Three Extemporaneously Compounded Oral Liquid Preparations
Author(s): Yamreudeewong Weeranuj, Dolence Eric Kurt, Teixeira M Glaucia
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
May/Jun 2019
Pg. 232
Clopidogrel 5 mg/mL in a Sugar-Free Syrup
Author(s): Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
May/Jun 2020
Pg. 252-262
Stability of Azathioprine, Clonidine Hydrochloride, Clopidogrel Bisulfate, Ethambutol Hydrochloride, Griseofulvin, Hydralazine Hydrochloride, Nitrofurantoin, and Thioguanine Oral Suspensions Compounded with SyrSpend SF pH4
Author(s): Polonini Hudson, Loures da Silva Sharlene, Neves Cunha Carolina, de Oliveira Ferreira Anderson, Anagnostou Korina, Dijkers Eli
Nov/Dec 2022
Pg. 446-466
Compounding with Biotechnology Products, Part 2: Product-specific Considerations
Author(s): Allen Loyd V Jr
Jul/Aug 2011
Pg. 340
Methylprednisolone 4-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2004
Pg. 46-48
Basics of Compounding for Disorders of the External Ear
Author(s): Allen Loyd V Jr
Sep/Oct 2023
Pg. 420
Nitazoxanide 20-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2018
Pg. 152
Spironolactone 5-mg/mL in Suspendit Oral Suspension
Author(s): Allen Loyd V Jr
Jul/Aug 2018
Pg. 318
Cinacalcet 5-mg/mL in Oral-Plus/Ora-Sweet Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2021
Pg. 420
Sorafenib 20-mg/mL in Oil Oral Suspension
Author(s): Allen Loyd V Jr
Jul/Aug 2021
Pg. 320
Apixaban 0.25-mg/mL Suspension for Enteral Feeding Tube
Author(s): Allen Loyd V Jr
Jul/Aug 2003
Pg. 272-275
Effectiveness in Oral Rhus toxicodendron Solution for Poison Ivy Prevention
Author(s): Stein Michael F, Parsons Eric
Jan/Feb 2021
Pg. 43
Amlodipine Besylate 0.5-mg/mL to 10-mg/mL in SuspendIt Oral Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2022
Pg. 148
Propranolol 2 mg/mL and 5 mg/mL in Ora-Blend SF Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2021
Pg. 414
Clonidine 0.01-mg/mL in Ora-Blend Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2021
Pg. 44
Clonidine 0.01-mg/mL in Oral Mix and Oral Mix SF Suspension
Author(s): Allen Loyd V Jr